The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
Hepatocellular carcinoma (HCC) is the main type of liver cancer. In the majority of cases, HCC is diagnosed at the advanced stage, leading to poor prognosis. In recent years, many efforts have been devoted to investigating potential new and more effective drugs and, indeed, the treatment armamentari...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ee2b4af0422447c7bcd37bfe2b45c3b5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Francesca Matilde Schipilliti |e author |
| 700 | 1 | 0 | |a Ingrid Garajová |e author |
| 700 | 1 | 0 | |a Giulia Rovesti |e author |
| 700 | 1 | 0 | |a Rita Balsano |e author |
| 700 | 1 | 0 | |a Federico Piacentini |e author |
| 700 | 1 | 0 | |a Massimo Dominici |e author |
| 700 | 1 | 0 | |a Fabio Gelsomino |e author |
| 245 | 0 | 0 | |a The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review |
| 260 | |b MDPI AG, |c 2021-01-01T00:00:00Z. | ||
| 500 | |a 10.3390/ph14010043 | ||
| 500 | |a 1424-8247 | ||
| 520 | |a Hepatocellular carcinoma (HCC) is the main type of liver cancer. In the majority of cases, HCC is diagnosed at the advanced stage, leading to poor prognosis. In recent years, many efforts have been devoted to investigating potential new and more effective drugs and, indeed, the treatment armamentarium for advanced HCC has broadened tremendously, with targeted- and immune-therapies, and probably the combination of both, playing pivotal roles. Together with new established knowledge, many issues are emerging, with the role of neoadjuvant/adjuvant settings, the definition of the best transitioning time from loco-regional treatments to systemic therapy, the identification of potential predictive biomarkers, and radiomics being just some of the topics that will have to be further explored in the next future. Clearly, the current COVID-19 pandemic has influenced the management of HCC patients and some considerations about this topic will be elucidated. | ||
| 546 | |a EN | ||
| 690 | |a hepatocellular carcinoma | ||
| 690 | |a target therapies | ||
| 690 | |a immune checkpoint inhibitors | ||
| 690 | |a combination therapies | ||
| 690 | |a COVID-19 | ||
| 690 | |a Medicine | ||
| 690 | |a R | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceuticals, Vol 14, Iss 1, p 43 (2021) | |
| 787 | 0 | |n https://www.mdpi.com/1424-8247/14/1/43 | |
| 787 | 0 | |n https://doaj.org/toc/1424-8247 | |
| 856 | 4 | 1 | |u https://doaj.org/article/ee2b4af0422447c7bcd37bfe2b45c3b5 |z Connect to this object online. |